Volume : 09, Issue : 11, November – 2022

Title:

36.APPLICATION OF FREEZE-DRYING TECHNIQUE IN THE DEVELOPMENT AND EVAULATION OF NANOSUSPENSION LOADED ODF OF ANTIPSYCHOTIC DRUG

Authors :

Tanushree C*, Gowrishankar, Chandrakala DC

Abstract :

Lurasidone HCl is antipsychotic drug belonging to BCS class II drug used for the treatment of schizophrenia. It was initially approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with schizophrenia. Our study was aimed at increasing the solubility of Lurasidone HCl by formulating nanosuspension and then incorporating it into oral dissolving films which were prepared by freeze drying technique to enhance Solubility and stability of film, Bioavailability and patient compliance. Reducing of particle size is achieved by formulating nanosuspension by High Pressure Homogenization Technique in which different stabilizers were screened for stabilizing agent in which Poloxamer 407 were selected based on the particle size and PDI.And the obtained nanosuspension is loaded into the ODF. The polymer is selected by the screening technique based on appearance, film forming, DT, and Folding endurance HPMC E15 is selected as a polymer and glycerine as a plasticizer. Optimization studies were carried out using 32 Central Composite Design. By considering all the evaluation parameters Optimized F7 formulation was the best among all the formulations with the DT 47secs, %Drug content 96.64, and folding endurance of 163.The F7 formulation was evaluated further by carrying out In-vitro dissolution studies and comparison with the In-vitro release profile of film prepared by solvent casting method. The F7 Freeze dried resulted in higher and increased drug release than the heat dried that is 96.11% at the 15th minute for freeze dried film whereas for heat dried 73.78 at 15th min. The drug release of the Marketed formulation was found to be 81.18% at the 120th minute.
Keywords: Lurasidone HCl, Nanosuspension, ODFs, Freeze dried, solvent casting.

Cite This Article:

Please cite this article in press Tanushree Chakraborty et al, Application Of Freeze-Drying Technique In The Development And Evaulation Of Nanosuspension Loaded Odf Of Antipsychotic Drug., Indo Am. J. P. Sci, 2022; 09(11).

Number of Downloads : 10

References:

1.Kahn, R. S. & Keefe, R. S. E. Schizophrenia is a cognitive illness: time for a change in focus. JAMA Psychiatry 70, 1107–1112 (2013).
2. A. Dolenc, J. Kristl, S. Baumgartner, O. Planinšek, Advantages of celecoxib nanosuspension formulation and transformation into tablets, Int. J. Pharm. 376 (2009) 204–212
3.Citrome L. Lurasidone in schizophrenia: new information about dosage and place in therapy. Adv Ther 2012; 29: 815-25.
4. Nakarani, M.; Misra, A.K.; Patel, J.K.; Vaghani, S.S. Itraconazole nanosuspension for oral delivery: Formulation, characterization and in vitro comparison with marketed formulation. Daru 2010, 18, 84–90.
5. Irfan M, Rabel S, Bukhtar Q, Qadir MI, Jabeen F, Khan A. Orally disintegrating films: A modern expansion in drug delivery system. Saudi pharmaceutical journal. 2016 Sep 1;24(5):537-46.
6. Bala R, Pawar P, Khanna S, Arora S. Orally dissolving strips: A new approach to oral drug delivery system. International journal of pharmaceutical investigation. 2013 Apr;3(2):67.
7.D.R. Choudhary, V.A. Patel, U.K. Chhalotiya, H.V. Patel, A.J. Kundawala, Development and characterization of pharmacokinetic parameters of fast dissolving films containing levocetirizine, Sci. Pharm. 80 (2012) 779–878.
8.A. Dinge, M. Nagarsenker, Formulation and evaluation of fast dissolving films for delivery of triclosan to the oral cavity, AAPS PharmSciTech 9 (2008) 349–356.
9. Soni MM, Patel KR. Formulation and evaluation of fast dissolving films of lurasidone hydrochloride. IntJPharm ResBioSci2016;5:101-23.
10. Senthilkumar K, Vijaya C. Formulation development of mouth dissolving film of etoricoxib for pain management. Advances inP’ceutics; 2015. https://doi.org/10.1155/2015/702963.
11. Satyanarayana, D.A.; Keshavarao, K.P. Fast disintegrating films containing anastrazole as a dosage form for dysphagia patients. Arch. Pharm. Res. 2012, 35, 2171–2182.
12. Shen, C.; Shen, B.; Xu, H.; Bai, J.; Dai, L.; Lv, Q.; Han, J.; Yuan, H. Formulation and optimization of a novel oral fast dissolving film containing drug nanoparticles by Box–Behnken design response surface methodology. Drug Dev. Ind. Pharm. 2014, 40, 649–656.
13.El-Dahmy, R.M.; Elsayed, I.; Elshafeey, A.H.; Abd El Gawad, N.A.; El-Gazayerly, O.N. Optimization of long circulating mixed polymeric micelles containing vinpocetine using simple lattice mixture design, in vitro and in vivo characterization.
14.Mishra R, Amin A. Manufacturing techniques of orally dissolving films. J Pharm Sci 2011;35:70–73